Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIDCR

Methods and Compositions for the Inhibition of HIV-1 Replication

  • Read more about Methods and Compositions for the Inhibition of HIV-1 Replication
US Application 60/516,734
Filed on 2003-11-04

Activation of Recombinant Diphtheria Toxin Fusion Proteins By Specific Proteases Highly Expressed on the Surface of Tumor Cells

  • Read more about Activation of Recombinant Diphtheria Toxin Fusion Proteins By Specific Proteases Highly Expressed on the Surface of Tumor Cells
US Application 60/468,577
Filed on 2003-05-06

Creation of Stable Recombinant Protective Antigen (RPA) Molecule by Deletions of the Chymotryspin-Sensitive Loop and the Furin -Cleavage Loop

  • Read more about Creation of Stable Recombinant Protective Antigen (RPA) Molecule by Deletions of the Chymotryspin-Sensitive Loop and the Furin -Cleavage Loop
US Application 60/402,285
Filed on 2002-08-09

Mammalian Sweet And Amino Acid Taste Receptors

  • Read more about Mammalian Sweet And Amino Acid Taste Receptors
US Application 60/358,925
Filed on 2002-02-22

Methods and composition For The Promotion of Hair growth Utilizing Act in Binding Peptides

  • Read more about Methods and composition For The Promotion of Hair growth Utilizing Act in Binding Peptides
US Application 60/351,386
Filed on 2002-01-25

MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS

  • Read more about MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS
US Application 60/302,898
Filed on 2001-07-03

A Composition And Method For Inhibting Angiogenesis And Cell Proliferation

  • Read more about A Composition And Method For Inhibting Angiogenesis And Cell Proliferation
US Application 60/314,561
Filed on 2001-08-23

SCALABLE PURIFICATION OF AAV2, AAV4 OR AAV5 USING ION-EXCHANGE CHROMATOGRAPHY.

  • Read more about SCALABLE PURIFICATION OF AAV2, AAV4 OR AAV5 USING ION-EXCHANGE CHROMATOGRAPHY.
US Application 60/381,180
Filed on 2002-05-17

Imaging The Activity of Extracellular Proteases In Cells Using Mutant Anthax Toxin Protective Antigens That Are Cleaved By Specific...

  • Read more about Imaging The Activity of Extracellular Proteases In Cells Using Mutant Anthax Toxin Protective Antigens That Are Cleaved By Specific...
US Application 60/317,550
Filed on 2001-09-05

Bone-Forming Composition, Methods for Making and Methods of Use

  • Read more about Bone-Forming Composition, Methods for Making and Methods of Use
US Application 60/351,795
Filed on 2002-01-25

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIDCR
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health